Healthcare resource use and clinical events associated with neutropenia among adult kidney transplant recipients receiving valganciclovir or ganciclovir prophylaxis: a matched case-control cohort study
Higher HCRU and clinical burden were observed within the first year following post-transplant neutropenia. New options for cytomegalovirus prophylaxis that are less likely to induce neutropenia are needed to improve patient outcomes.
Authors
- Pamela Moise
- Flavio Vincenti (ORCID: https://orcid.org/0000-0002-6701-4680)
- Abigail Zion (ORCID: https://orcid.org/0000-0001-6598-394X)
- Cheryl Xiang
- Weijia Wang (ORCID: https://orcid.org/0000-0002-7707-5022)
- Michael Wong (ORCID: https://orcid.org/0000-0002-3459-501X)
- Wei Gao (ORCID: https://orcid.org/0000-0001-9261-3127)
- A Beyer
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of California System (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/03007995.2025.2498674
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00